z-logo
open-access-imgOpen Access
The association of TAFI (Thrombin-activatable fibrinolysis inhibitor) with insulin resistance and components of metabolic syndrome in patients with metabolic syndrome
Author(s) -
Alev Kural,
Ahmet Omma,
Hatice Seval,
Macit Koldaş,
N. Yigit,
Tülay Omma
Publication year - 2010
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-0906-60
Subject(s) - medicine , metabolic syndrome , insulin resistance , hypertriglyceridemia , fibrinolysis , endocrinology , triglyceride , insulin , dyslipidemia , diabetes mellitus , cholesterol , disease
doi:10.3906/sag-0906-6

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom